CEC SpA /ID# 169872

Ñuñoa 7750495

0 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433 — Running, not enrolling